Literature DB >> 6818576

Effects of chlorpromazine and d-amphetamine on schedule-controlled and schedule-related behavior of rabbits.

J E Barrett, J A Stanley.   

Abstract

A lever-lifting response by Dutch Belted and New Zealand White rabbits was maintained in water-deprived animals by 0.26% saccharin solution and in food-deprived animals by food pellets under a multiple 3-min fixed-interval (FI) 30-response fixed-ratio (FR) schedule. Rabbits responding for the saccharin solution had food freely available during the session and in the home cage, whereas those responding for pellets had water continuously available during the session as well as in the home cage. Under nondrug conditions the FR and FI schedules controlled different rates and patterns of responding in the rabbit that were characteristic of those found with other species. In addition, eating or drinking occurred during the initial portion of the FI under the saccharin solution and initial food presentation schedules, respectively. Doses of d-amphetamine (0.1--10.0 mg/kg) increased responding under the FI and FR schedules of food delivery, but increased only FI responding maintained by the saccharin solution. Doses of 3.0--10.0 mg/kg d-amphetamine produced extremely high (300--800% of control) rates of stereotyped perseverative level responding. Schedule-related eating or drinking were unaffected or decreased at doses of d-amphetamine that increased schedule-controlled responding. Chlorpromazine (0.03--0.3 mg/kg) increased FI responding maintained both by saccharin and food, whereas FR responding generally was unaffected at these dose levels; eating but not drinking was increased with chlorpromazine. Since the behavioral effects of drugs such as amphetamine and chlorpromazine differ somewhat in the rabbit from those found with other typically studied nonhuman mammals, further studies with the rabbit may yield useful information for comparative behavioral pharmacology.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6818576     DOI: 10.1007/bf00428150

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  15 in total

1.  The rabbit as a subject in behavioral research.

Authors:  H B Rubin; H J Brown
Journal:  J Exp Anal Behav       Date:  1969-07       Impact factor: 2.468

2.  Effect of intracerebroventricular bradykinin, angiotensin II, and substance P on multiple fixed-interval fixed-ratio responding in rabbits.

Authors:  F G Graeff; E A Arisawa
Journal:  Psychopharmacology (Berl)       Date:  1978-04-14       Impact factor: 4.530

3.  Effects of d-amphetamine on schedule-controlled key pressing and drinking in the chimpanzee.

Authors:  L D Byrd
Journal:  J Pharmacol Exp Ther       Date:  1973-06       Impact factor: 4.030

4.  Modification of the effects of chlorpromazine on behavior in the chimpanzee.

Authors:  L D Byrd
Journal:  J Pharmacol Exp Ther       Date:  1974-04       Impact factor: 4.030

5.  Role of chlorpromazine in maintaining timing behavior in chronic schizophrenics.

Authors:  H V Angle
Journal:  Psychopharmacologia       Date:  1973-01-01

6.  Stereotyped activities produced by amphetamine in several animal species and man.

Authors:  A Randrup; I Munkvad
Journal:  Psychopharmacologia       Date:  1967

7.  Drug effects in squirrel monkeys trained on a multiple schedule with a punishment contingency.

Authors:  H M Hanson; J J Witoslawski; E H Campbell
Journal:  J Exp Anal Behav       Date:  1967-11       Impact factor: 2.468

8.  The dose-response effect of amphetamine upon avoidance behaviour in the rat seen as a function of increasing stereotypy.

Authors:  M Lyon; A Randrup
Journal:  Psychopharmacologia       Date:  1972

9.  Effect of intracerebroventricular bradykinin and related peptides on rabbit operant behavior.

Authors:  J C Melo; F G Graeff
Journal:  J Pharmacol Exp Ther       Date:  1975-04       Impact factor: 4.030

Review 10.  The nature and determinants of adjunctive behavior.

Authors:  J L Falk
Journal:  Physiol Behav       Date:  1971-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.